Title:
ビスフェノール誘導体、及びアンドロゲン受容体活性調節因子としてのそれらの使用
Document Type and Number:
Japanese Patent JP7142577
Kind Code:
B2
Abstract:
Compounds having a structure of Formula I:or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R1, R2, R3, R11a, R11b, R11c, R11d, and X, are as defined herein, are provided. Uses of such compounds for modulating androgen receptor activity, imaging diagnostics in cancer and therapeutics, and methods for treatment of subjects in need thereof, including prostate cancer are also provided.
Inventors:
Andersen, Raymond
Sudder, Marianne Dorothy
Gian, Kunzong
Mauji, Nasrin Earl.
Wan, Jun
Banuelos, Carmen Adriana
Yang, Yuchi
Sudder, Marianne Dorothy
Gian, Kunzong
Mauji, Nasrin Earl.
Wan, Jun
Banuelos, Carmen Adriana
Yang, Yuchi
Application Number:
JP2018554381A
Publication Date:
September 27, 2022
Filing Date:
April 18, 2017
Export Citation:
Assignee:
British Columbia Cancer Agency Branch
The University of British Columbia
The University of British Columbia
International Classes:
C07C217/34; A61K31/085; A61K31/10; A61K31/138; A61K31/18; A61K31/215; A61K45/00; A61P13/08; A61P15/00; A61P17/00; A61P17/02; A61P17/14; A61P21/00; A61P27/02; A61P35/00; A61P35/04; A61P43/00; C07C233/18; C07C311/04; C07C311/51; C07C317/18; C07C317/22
Domestic Patent References:
| JP60209580A | ||||
| JP63317539A | ||||
| JP2018502867A | ||||
| JP2013516435A | ||||
| JP2011526250A |
Foreign References:
| WO2015031984A1 | ||||
| WO2012139039A2 | ||||
| US20130109758 | ||||
| US3074974 | ||||
| WO2014179867A1 | ||||
| US20150010469 | ||||
| US20130336962 |
Attorney, Agent or Firm:
Shusaku Yamamoto
Morishita Natsuki
Morishita Natsuki
Previous Patent: Pleochroic glass with praseodymium and neodymium
Next Patent: Pegylated Carfilzomib Compound
Next Patent: Pegylated Carfilzomib Compound